Viewing Study NCT00146757


Ignite Creation Date: 2025-12-24 @ 6:57 PM
Ignite Modification Date: 2026-01-18 @ 9:46 PM
Study NCT ID: NCT00146757
Status: COMPLETED
Last Update Posted: 2015-04-03
First Post: 2005-09-02
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study Evaluating the Safety and Pharmacokinetics of Aldurazyme® (Laronidase) in MPS I Patients Less Than 5 Years Old
Sponsor: Genzyme, a Sanofi Company
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ALID-014-02
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Medical Monitor
Old Organization: Genzyme Corporation

Collaborators

Collaborators

Name Class View
None INDUSTRY View